English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Exercise and antioxidant nutrition based food are good prevention for Alzheimer’s Disease. But why are these preventions effective to prevent AD? Recent our findings that human AD patients could not excrete homocysteic acid (HA) into urine and their blood HA was a good marker for the cognitive decline in AD, which indicated that the treatment for HA in blood can be a good therapy for the recovery of cognitive decline of AD. Methods: We have developed new food supplement which can compete with HA and also reduce the sulfite group of HA. We named this supplement as HBF. We observed the effect of HBF on 91 AD patients as an open labeled clinical trial. Results: In fact we have developed the brain food which can decrease HA in blood. And we have observed that the open-labeled clinical trial of HBF (hydrogen brain food) for 91 AD patients was good positive results. Even the final stage of AD patients, their cognitive behavior was surprisingly recovered. Discussions: From our observations, it is suggested that targeting homocysteic acid in blood is a good therapy for the cognitive recovery of AD and also suggested that exercise and antioxidant nutrition food also can decrease HA in blood partially and these methods are good preventions for AD, because normal person’s HA level in blood is very low.

international journal of clinical research and trials

Open Label Clinical Trial of Hydrogen Brain Food for 91 Alzheimer's Patients (Targeting Therapy for Homocysteic Acid in Blood is an Alzheimer's Cognitive Recovery)